Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients [Phase 2]
The document reports Phase 2 trial results evaluating tideglusib for mild-to-moderate Alzheimer's disease, focusing on efficacy, safety, and…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease [Phase 3]
Pfizer conducted an extension of the Phase 3 B1451006 protocol to evaluate the safety and efficacy of Dimebon (latrepirdine) in moderate-to-…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease [Phase 3]
Pfizer terminated a Phase 3 efficacy study of Dimebon (latrepirdine) for Alzheimer's disease; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
This clinical trial update reports the long-term safety and efficacy follow-up of subjects who completed the Phase I study of Neurostem-AD.
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine [Phase 2]
A Phase 2 study evaluating the efficacy and tolerability of MLC601 in patients with mild to moderate Alzheimer's disease who were unable to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers [Phase 2]
Phase II imaging study evaluating [18F]AV-45 (florbetapir) for amyloid imaging in patients with mild cognitive impairment and Alzheimer's di…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders [NA]
This randomized trial assessed the combined effects of exercise and social interaction in a community-based sample of non-demented Chinese e…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
Clinical trial update for the Clinical Research Center for Dementia of South Korea (CREDOS/CRCD) at Samsung Medical Center, involving Alzhei…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers [Phase 1]
A Phase 1 trial evaluating the effect of PF-04360365 on amyloid-beta in patients with Alzheimer's disease and in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's [Phase 2]
A Phase 2 biomarker study evaluating solanezumab in patients with and without Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Effect of LY2062430 on the Progression of Alzheimer's Disease [Phase 3]
Phase 3 trial evaluating LY2062430 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline [Phase 3]
Phase 3 trial comparing two rivastigmine transdermal patch doses (10 cm^2 vs 15 cm^2) in Alzheimer’s disease patients with cognitive decline…
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days) [Phase 2]
A Phase 2 trial (SNIFF 120) tested intranasal insulin for forgetfulness in people with Mild cognitive impairment and Alzheimer's disease; th…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease [Phase 1]
A Phase 1 safety study of HPP854 in subjects with mild cognitive impairment or mild Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 trial assessing safety and tolerability of memantine in moderate to severe Alzheimer's disease; the study was terminated and results…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Exploratory and Safety Study of [F-18]W372 [EARLY_Phase 1]
Siemens Molecular Imaging completed an exploratory and safety Phase 1 study of the PET tracer [F-18]W372 for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) [Phase 1, Phase 2]
A clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating PET tracers 18F-AV-133 and 18F-AV-45 for imaging dement…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease [Phase 4]
Phase 4 trial evaluating whether galantamine can modulate circadian rhythm in patients with mild to moderate Alzheimer's disease; the study …
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Alzheimer's in Long-Term Care--Treatment for Agitation [NA]
This clinical trial update reports results for a treatment of agitation in Alzheimer's disease patients in long-term care; the study has com…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease [Phase 4]
Phase 4 clinical trial assessing the impact of choline acetyltransferase and apolipoprotein Epsilon gene polymorphisms on response to donepe…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals [Phase 2]
This Phase 2 trial evaluated whether the [18F]-AV-45 PET scan (Florbetapir F-18) can distinguish Alzheimer's disease from cognitively normal…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
This clinical trial update reports the performance of AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, in US patients n…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease [Phase 3]
Phase 3 clinical trial evaluating galantamine for Alzheimer's disease has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) [Phase 3]
Phase 3 clinical trial update evaluating inter-reader reliability using imaging in Alzheimer's disease and mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease [Phase 3]
Open-label extension study update for 23 mg donepezil sustained-release in moderate to severe Alzheimer's disease; study completed with resu…